Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized Study

BACKGROUND: ND0612 is a continuous, subcutaneous levodopa/carbidopa delivery system in development for patients with Parkinson’s disease (PD) experiencing motor fluctuations OBJECTIVE: Evaluate the efficacy and safety of two ND0612 dosing regimens in patients with PD. METHODS: This was a 28-day open...

Descripción completa

Detalles Bibliográficos
Autores principales: Olanow, C. Warren, Espay, Alberto J., Stocchi, Fabrizio, Ellenbogen, Aaron L., Leinonen, Mika, Adar, Liat, Case, Ryan J., Orenbach, Shir Fuchs, Yardeni, Tami, Oren, Sheila, Poewe, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2021
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990424/
https://www.ncbi.nlm.nih.gov/pubmed/33164945
http://dx.doi.org/10.3233/JPD-202285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990424/
https://www.ncbi.nlm.nih.gov/pubmed/33164945
http://dx.doi.org/10.3233/JPD-202285

Ejemplares similares